Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose

Frank Schraml, Kewei Chen, Napatkamon Ayutyanont, Roontiva Auttawut, Jessica B S Langbaum, Wendy Lee, Xiaofen Liu, Dan Bandy, Stephanie Q. Reeder, Gene E. Alexander, Richard John Caselli, Adam S. Fleisher, Eric M. Reiman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background:We introduced a hypometabolic convergence index (HCI) to characterize in a single measurement the extent to which a person's fluorodeoxyglucose positron emission tomogram (FDG PET) corresponds to that in Alzheimer's disease (AD). Apolipoprotein E ε4 (APOE ε4) gene dose is associated with three levels of risk for late-onset AD. We explored the association between gene dose and HCI in cognitively normal ε4 homozygotes, heterozygotes, and non-carriers.Methods:An algorithm was used to characterize and compare AD-related HCIs in cognitively normal individuals, including 36 ε4 homozygotes, 46 heterozygotes, and 78 non-carriers.Results:These three groups differed significantly in their HCIs (ANOVA, p = 0.004), and there was a significant association between HCIs and gene dose (linear trend, p = 0.001).Conclusions:The HCI is associated with three levels of genetic risk for late-onset AD. This supports the possibility of using a single FDG PET measurement to help in the preclinical detection and tracking of AD.

Original languageEnglish (US)
Article numbere67163
JournalPLoS One
Volume8
Issue number6
DOIs
StatePublished - Jun 26 2013

Fingerprint

Apolipoprotein E4
apolipoprotein E
Alzheimer disease
Alzheimer Disease
Genes
Human computer interaction
dosage
Homozygote
Positrons
Heterozygote
homozygosity
genes
heterozygosity
electrons
Electrons
Analysis of variance (ANOVA)
Analysis of Variance
analysis of variance

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Schraml, F., Chen, K., Ayutyanont, N., Auttawut, R., Langbaum, J. B. S., Lee, W., ... Reiman, E. M. (2013). Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. PLoS One, 8(6), [e67163]. https://doi.org/10.1371/journal.pone.0067163

Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. / Schraml, Frank; Chen, Kewei; Ayutyanont, Napatkamon; Auttawut, Roontiva; Langbaum, Jessica B S; Lee, Wendy; Liu, Xiaofen; Bandy, Dan; Reeder, Stephanie Q.; Alexander, Gene E.; Caselli, Richard John; Fleisher, Adam S.; Reiman, Eric M.

In: PLoS One, Vol. 8, No. 6, e67163, 26.06.2013.

Research output: Contribution to journalArticle

Schraml, F, Chen, K, Ayutyanont, N, Auttawut, R, Langbaum, JBS, Lee, W, Liu, X, Bandy, D, Reeder, SQ, Alexander, GE, Caselli, RJ, Fleisher, AS & Reiman, EM 2013, 'Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose', PLoS One, vol. 8, no. 6, e67163. https://doi.org/10.1371/journal.pone.0067163
Schraml F, Chen K, Ayutyanont N, Auttawut R, Langbaum JBS, Lee W et al. Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. PLoS One. 2013 Jun 26;8(6). e67163. https://doi.org/10.1371/journal.pone.0067163
Schraml, Frank ; Chen, Kewei ; Ayutyanont, Napatkamon ; Auttawut, Roontiva ; Langbaum, Jessica B S ; Lee, Wendy ; Liu, Xiaofen ; Bandy, Dan ; Reeder, Stephanie Q. ; Alexander, Gene E. ; Caselli, Richard John ; Fleisher, Adam S. ; Reiman, Eric M. / Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose. In: PLoS One. 2013 ; Vol. 8, No. 6.
@article{26dee39cb4c94a298cdd811cdf3434c0,
title = "Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose",
abstract = "Background:We introduced a hypometabolic convergence index (HCI) to characterize in a single measurement the extent to which a person's fluorodeoxyglucose positron emission tomogram (FDG PET) corresponds to that in Alzheimer's disease (AD). Apolipoprotein E ε4 (APOE ε4) gene dose is associated with three levels of risk for late-onset AD. We explored the association between gene dose and HCI in cognitively normal ε4 homozygotes, heterozygotes, and non-carriers.Methods:An algorithm was used to characterize and compare AD-related HCIs in cognitively normal individuals, including 36 ε4 homozygotes, 46 heterozygotes, and 78 non-carriers.Results:These three groups differed significantly in their HCIs (ANOVA, p = 0.004), and there was a significant association between HCIs and gene dose (linear trend, p = 0.001).Conclusions:The HCI is associated with three levels of genetic risk for late-onset AD. This supports the possibility of using a single FDG PET measurement to help in the preclinical detection and tracking of AD.",
author = "Frank Schraml and Kewei Chen and Napatkamon Ayutyanont and Roontiva Auttawut and Langbaum, {Jessica B S} and Wendy Lee and Xiaofen Liu and Dan Bandy and Reeder, {Stephanie Q.} and Alexander, {Gene E.} and Caselli, {Richard John} and Fleisher, {Adam S.} and Reiman, {Eric M.}",
year = "2013",
month = "6",
day = "26",
doi = "10.1371/journal.pone.0067163",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose

AU - Schraml, Frank

AU - Chen, Kewei

AU - Ayutyanont, Napatkamon

AU - Auttawut, Roontiva

AU - Langbaum, Jessica B S

AU - Lee, Wendy

AU - Liu, Xiaofen

AU - Bandy, Dan

AU - Reeder, Stephanie Q.

AU - Alexander, Gene E.

AU - Caselli, Richard John

AU - Fleisher, Adam S.

AU - Reiman, Eric M.

PY - 2013/6/26

Y1 - 2013/6/26

N2 - Background:We introduced a hypometabolic convergence index (HCI) to characterize in a single measurement the extent to which a person's fluorodeoxyglucose positron emission tomogram (FDG PET) corresponds to that in Alzheimer's disease (AD). Apolipoprotein E ε4 (APOE ε4) gene dose is associated with three levels of risk for late-onset AD. We explored the association between gene dose and HCI in cognitively normal ε4 homozygotes, heterozygotes, and non-carriers.Methods:An algorithm was used to characterize and compare AD-related HCIs in cognitively normal individuals, including 36 ε4 homozygotes, 46 heterozygotes, and 78 non-carriers.Results:These three groups differed significantly in their HCIs (ANOVA, p = 0.004), and there was a significant association between HCIs and gene dose (linear trend, p = 0.001).Conclusions:The HCI is associated with three levels of genetic risk for late-onset AD. This supports the possibility of using a single FDG PET measurement to help in the preclinical detection and tracking of AD.

AB - Background:We introduced a hypometabolic convergence index (HCI) to characterize in a single measurement the extent to which a person's fluorodeoxyglucose positron emission tomogram (FDG PET) corresponds to that in Alzheimer's disease (AD). Apolipoprotein E ε4 (APOE ε4) gene dose is associated with three levels of risk for late-onset AD. We explored the association between gene dose and HCI in cognitively normal ε4 homozygotes, heterozygotes, and non-carriers.Methods:An algorithm was used to characterize and compare AD-related HCIs in cognitively normal individuals, including 36 ε4 homozygotes, 46 heterozygotes, and 78 non-carriers.Results:These three groups differed significantly in their HCIs (ANOVA, p = 0.004), and there was a significant association between HCIs and gene dose (linear trend, p = 0.001).Conclusions:The HCI is associated with three levels of genetic risk for late-onset AD. This supports the possibility of using a single FDG PET measurement to help in the preclinical detection and tracking of AD.

UR - http://www.scopus.com/inward/record.url?scp=84879472461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879472461&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0067163

DO - 10.1371/journal.pone.0067163

M3 - Article

C2 - 23840615

AN - SCOPUS:84879472461

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e67163

ER -